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Abstract
Background: It is unclear if the rat myocardium undergoes the same rapid reductions in protein content that are classically
observed in fast-twitch skeletal muscle during endotoxaemia.
Methodology/Principal Findings: To investigate this further, and to determine if there is any divergence in the response of
skeletal muscle and myocardium in the mechanisms that are thought to be largely responsible for eliciting changes in
protein content, Sprague Dawley rats were implanted with vascular catheters and administered lipopolysaccharide (LPS;
150 mgk g
21 h
21) intravenously for 2 h, 6 h or 24 h (saline administered control animals were also included), after which the
extensor digitorum longus (EDL) and myocardium were removed under terminal anaesthesia. The protein-to-DNA ratio, a
marker of protein content, was significantly reduced in the EDL following 24 h LPS administration (23%; P,0.05), but was
no different from controls in the myocardium. At the same time point, a significant increase in MAFbx/atrogin-1 and MuRF1
mRNA (3.760.7- and 19.561.9-fold increase vs. controls, respectively; P,0.05), in addition to protein levels of a1-3, 5–7
subunits of the 20S proteasome, were observed in EDL but not myocardium. In contrast, elevations in phosphorylation of
p70 S6K residues Thr
421/Ser
424, and 4E-BP1 residues Thr
37/Thr
46 (P,0.05), consistent with an elevation in translation
initiation, were seen exclusively in the myocardium of LPS-treated animals.
Conclusions/Significance: In summary, these findings suggest that the myocardium does not undergo the same catabolic
response as skeletal muscle during early endotoxaemia, partly due to the absence of transcriptional and signalling events in
the myocardium typically associated with increased muscle proteolysis and the suppression of protein synthesis.
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Introduction
A well known consequence of sepsis is the rapid and debilitating
loss of skeletal muscle mass, which appears the result of a
coordinated reduction of muscle protein synthesis together with an
enhancement of proteasomal mediated muscle protein breakdown
[1,2]. However, the effects of sepsis on the mechanisms that
regulate protein turnover in the myocardium are, in comparison,
poorly understood.
We have recently shown the induction of lipopolysaccharide
(LPS)-induced endotoxaemia in rodents to result in the reduction
of total AKT protein levels, decreased cytosolic Foxo1 and Foxo3
phosphorylation, and increased levels of MAFbx/atrogin-1 protein
and MuRF1 mRNA in fast-twitch skeletal muscle [3], where
MAFbx/atrogin-1 and MuRF1 are considered important in the
development of skeletal muscle proteolysis during catabolic events
[4–6]. These in vivo findings are important because, when viewed
in conjunction with similar observations in C2C12 cells [7,8], they
suggest AKT as a regulator of both protein translation initiation
and ubiquitin-proteasome (UP) mediated muscle proteolysis.
Indeed, AKT is well known as an upstream regulator of translation
initiation, where increases in AKT activity lead to increases in
both eIF2B guanidine exchange factor activity and eIF4F
assembly, via the phosphorylation and subsequent inhibition of
GSK3b and 4E-BP1, respectively [9], processes that are pivotal to
the correct formation of a functioning ribosomal initiation
complex for translation initiation to occur. Furthermore, when
activated, AKT can phosphorylate the forkhead Foxo family of
transcription factors, leading to their transportation away from the
nucleus and into the cytoplasm where they are inactive [7,8].
However, when present in the nucleus, Foxo1, Foxo3 and Foxo4
can induce the transcription of the two muscle-specific ubiquitin
ligases, MAFbx/atrogin-1 and MuRF1, which are thought
responsible for the specific targeting of proteins for subsequent
degradation by the proteasome [7,8].
Interestingly, while numerous studies have focused on skeletal
muscle when considering the endotoxaemia-induced derange-
ments that occur in the pathways that regulate translation
initiation [10–12] and UP-mediated proteolysis [13,14], few have
examined if these pathways are likewise perturbed in the
myocardium. Moreover, from the limited evidence available, it
is currently not possible to discern if the rat myocardium
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observed in rodent fast-twitch skeletal muscle. Conflicting reports
detailing both a decline [15] and the maintenance [16,17] of
myocardial protein content following experimentally induced
endotoxaemia have been described. Thus, we sought to determine
if an i.v., non-lethal dose of bacterial LPS, administered to
conscious rats, resulted in a change in myocardial protein content,
and examined in the same tissue, transcriptional and signalling
events that are typically associated with endotoxaemia-induced
protein loss in fast-twitch skeletal muscle [18]. An attempt was also
made to relate any observed differences between myocardial and
skeletal muscle tissue to localised levels of the two cytokines, tumor
necrosis factor-alpha (TNFa) and interleukin-6 (IL-6), as they
have, in part, been implicated in eliciting reductions in muscle
protein content [19,20]. Here we show that while significant
declines in skeletal muscle protein content are observed in
response to LPS infusion, myocardial protein content is main-
tained at normal levels. Furthermore, we present evidence to
suggest that this is in part due to a differential response to
endotoxin in the processes that govern UP-mediated degradation
and translation initiation in these two tissues.
Materials and Methods
Ethics Statement
All procedures involving live animals, as detailed below, were
approved by the University of Nottingham Ethical Review
Committee and were performed under U.K. Home Office Project
and Personal License authority.
Animal preparation and experimental protocol
Sixty four male Sprague-Dawley rats (380–480 g; Charles River,
Margate, UK) were anesthetised using fentanyl (Janssen-Cilag,
High Wycombe, UK) and medetomidine (Domitor, Pfizer,
Sandwich, UK; 300 mg?kg
21 of each i.p.) and had intravenous
(right jugular vein) catheters implanted for the administration of
substances. In animals designated for 24 h LPS treatment (see
below) catheters were also implanted in the distal abdominal aorta
(via the ventral caudal artery) for monitoring of blood pressure (BP)
and heart rate (HR). We have previously found saline administra-
tion, as used in control animals, to have no significant effect on
baseline cardiovascular status over 24 h [21], and therefore the BP
and HR of control animals were not monitored. Anaesthesia was
reversed with atipamezole (Antisedan, Pfizer, Sandwich, UK) and
nalbuphine (Bristol-Myers Squibb, Uxbridge, UK; 1 mg?kg
21 of
eachs.c.), with the latter alsoprovidinganalgesia.Ratswere allowed
to recover overnight in their home cages and were given free access
to both food and water. A counter-balanced tether system
connected to a harness and fitted to the rat carried the catheters,
and allowed relatively unrestricted movement within the home
cage. Double channel swivel systems were constructed according to
[22] which enabled the continuous administration of saline or LPS
to the unrestrained animals.
Prepared rats were divided into 6 groups; 3 groups were infused
with sterile saline (0.4 ml h
21) for either 2 h (n=8), 6 h (n=7) or
24 h (n=8), and the remaining 3 groups received a continuous
infusion of LPS (E. coli, serotype 0127:B8, Sigma, Poole, UK;
dissolved in sterile, isotonic saline; 150 mgk g
21 h
21) for either 2 h
(n=8), 6 h (n=8) or 24 h (n=6). At the specified time after onset
of saline or LPS infusion, animals were terminally anesthetised (i.v.
sodium pentobarbital, Sagatal, Rho ˆne Me ´rieux, Harlow, UK).
The EDL muscle was removed from the left hind-limb during
anaesthesia, and was immediately frozen and stored in liquid
nitrogen. The myocardium was then rapidly removed and freeze-
clamped (whilst still beating) with liquid nitrogen-cooled alumin-
ium tongs, and subsequently transferred to liquid nitrogen for
storage. Two 24 h LPS-infused rats and one 6 h saline-infused rat
stopped breathing before removal of tissues was complete, and
were excluded from the study. To examine muscle signalling
events associated with early endotoxaemia, 16 additional animals
underwent the procedures described above and received either
LPS (n=8) or saline (n=8) i.v. for a 24 h period. This sole time-
point was selected as previous work emanating from our
laboratory had shown 24 h LPS administration was sufficient to
result in significant suppression of AKT-mediated signalling events
in fast-twitch skeletal muscle [3]. The EDL and myocardium
removed from these animals were used exclusively for the
investigation of changes in protein and phosphorylation levels of
translation initiation signalling events.
Cardiovascular recordings
Muscle contraction is well known to modulate processes that
control muscle mass [23] and we have previously shown LPS
administration to result in prolonged and persistent tachycardia
[24]. Therefore, to examine any association between the observed
tachycardia seen in LPS-treated animals and myocardial tran-
scriptional and signalling events, recordings of heart rate (HR)
were made. This was accomplished by using a customised,
computer-based system (Haemodynamics Data Acquisition Sys-
tem, University of Limburg, Netherlands) connected to a BP
transducer amplifier (Gould model 13-4615-50; Gould Instrument
Systems Inc., Valley View, USA), providing both HR and BP
recordings. Data were sampled by the Haemodynamics Data
Acquisition System every 2 ms, averaged each cardiac cycle, and
stored to disc every 5 s. Data were analysed off-line (Datview;
University of Maastricht, Netherlands) and measurements were
made under resting conditions and at 1 h intervals for the first 6 h
after LPS administration and again at 24 h.
Alkaline soluble protein/DNA ratio
The alkaline soluble protein (ASP)/DNA ratio may be used as a
measure of net protein catabolism in skeletal muscle [3,25,26].
Approximately 5 mg of muscle tissue was freeze-dried and
powdered, with care taken to remove any connective tissue
present. ASP and DNA were individually isolated from the
powdered muscle using repeated perchloric acid extractions and
washings, with the ASP being ultimately extracted by the addition
of potassium hydroxide. ASP concentration was determined using
the method of Lowry [27], and DNA was quantified using a
modification of the diphenyl-amine reaction described by Munro
and Fleck [28].
Real-time quantitative PCR
Total RNA was extracted from approximately 30 mg of frozen
muscle using a TRIzolH (Invitrogen) based method that has been
described in detail elsewhere [29]. After subsequent extraction,
RNA samples were quantified by measuring their absorbance at
260 nm and 280 nm. Reverse transcription was carried out using
1.0 mg of total RNA in a total volume of 30 ml, containing MMLV
reverse transcriptase, random hexamer primers, RNase inhibitor
N2511, and the four nucleotides dATP, dGTP, dCTP and dUTP
(all sourced from Promega, Southampton, UK). After incubation
at 42uC for 1 h, freshly synthesised cDNA was diluted four-fold
with RNase-free H2O.
Six, previously designed, Assay-on-Demand TaqmanH primer
and probe sets were purchased (Applied Biosystems), MuRF1
(#Rn00590197_m1); MAFbx/atrogin-1 (#Rn00591730_m1);
20S proteasome subunit a1 (PSMA1; #Rn00568675_m1); TNFa
Endotoxin and the Myocardium
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ing gene hydroxymethlybilane synthase (HMBS; #Rn00565886_m1).
Each Taqman primer and probe set was validated by performing
real-time PCR with a series of 4-fold cDNA template dilutions to
obtain standard curves of cycle threshold number (Ct) against log
relative concentration (data not shown). All six genes were found to be
amplified with equal efficiency allowing the subsequent use of the
comparative Ct method (DDCt) for the relative quantification of gene
expression. All sample and non-template control reactions were
performed in the ABI Prism 7000 Sequence Detection System
(Applied Biosystems) in triplicate. The Ct values for each triplicate were
averaged and the DCt calculated by the subtraction of the
corresponding mean Ct value for the normalisation gene HMBS.
The expression of HMBS was previously found to be unaffected by
LPS-infusion within myocardium and skeletal muscle (data not shown).
Real-time PCR was performed using PCR Universal Master Mix
(Applied Biosystems) in a MicroAmp 96-well reaction plate. Each well
contained 2 ml cDNA template, 12.5 ml PCR Master Mix and 1.25 ml
of Assay on Demand primer/probe mix in a reaction volume of 25 ml.
Data from the LPS-treatment group was normalised to the average of
the saline (control) group for each muscle tissue type and time point.
Protein levels of 20S proteasome subunits a1-3 & 5–7
Proteins were extracted by homogenisation in 0.8 ml of pH 7.5
Tris-EDTA buffer, and subsequently quantified and normalised
using the Lowry method [27]. Protein samples (20 mg) were
separated by molecular weight on 5–20% SDS-PAGE gels in 1x
Tris/Glycine/SDS buffer (Biorad, Hemel Hempstead, UK) and
transferred overnight to nitrocellulose membranes (Amersham
Biosciences, Little Chalfont, UK). Equal loading of samples was
confirmed by Ponceau S staining of membranes. Membranes were
blocked by incubation for 1 h with 4% (w/v) milk protein in tris-
buffered saline, and subsequently probed with polyclonal rabbit
anti-a1–3, 5–7 subunits of the proteasome (Biomol, Exeter, UK)
for 1 h, peroxidase-conjugated donkey anti-rabbit (Amersham
Biosciences) for 1 h, and visualised by enhanced chemilumines-
cence plus (Amersham Biosciences). Thus, the primary antibody
cross reacts with the a1 subunit examined by RT-PCR, in addition
to other core proteasome subunits.
Protein and phosphorylation levels of AKT, p70 S6K and
4E-BP1
Proteins were extracted from approximately 30 mg of muscle by
homogenisation in 0.8 ml of pH 7.5 homogenisation buffer,
consisting of 50 mM Tris-HCL, 1 mM EDTA, 1 mM EGTA, 1%
(v/v) TritonH X-100 and 0.1% (v/v) b-mercaptoethanol. In
addition, to every 10 ml of homogenisation buffer was added 1
tablet of a protease inhibitor cocktail (Roche, Burgess Hill, UK)
and 100 ml of phosphatase inhibitor cocktail II (Sigma). Extracted
proteins were subsequently quantified using the method of Lowry
et al. [27] and diluted to a concentration of 2 mg/ml with 2x SDS
buffer (25% (w/v) glycerol, 16% (v/v) 0.625 M Tris pH 6.8, 4%
(w/v) SDS, 0.0025% (w/v) bromophenol blue and 10% (v/v)
b-mecaptoethanol). Protein samples (50 mg) were separated by
molecular weight on 5–20% SDS-PAGE gels in 1x Tris/Glycine/
SDS buffer (Biorad) and transferred overnight at 4uC to PVDF
membranes (Amersham Bioscience). Equal loading of samples was
confirmed by Ponceau S staining. Membranes were subsequently
blocked with 5% (w/v) bovine serum albumin in 1x tris-buffered
saline for 1 h, followed by incubation overnight at 4uC with a
primary polyclonal rabbit antibody (all sourced from Cell
Signaling Technology Inc., Danvers, USA) for either AKT (Cat
No. #9272), AKT Ser
473 (#4058), p70 S6K (#9202), p70 S6K
Thr
421/Ser





46 by mTOR does not prevent
the binding of 4E-BP1 to eIF4E, it is thought to be a necessary
prerequisite for subsequent phosphorylation at Ser
65 and Thr
70;a s
such, the phosphorylation state of 4E-BP1 is considered a good
surrogate measure of translation initiation. This was followed by
incubation with peroxidase-conjugated donkey anti-rabbit for 1 h
(Amersham Biosciences), and subsequently visualised by enhanced
chemiluminescence plus (Amersham Biosciences). Developed films
were digitised, and band densities determined using GeneTools
software (Syngene, Cambridge, UK).
Statistical analysis
All data reported are means6S.E.M. For within-group analysis
of HR and BP data, a nonparametric equivalent of analysis of
variance allowing for multiple comparisons was utilised (Fried-
man’s test). Where temporal measures of mRNA and protein levels
have been made, the effects of time, treatment and time-treatment
interaction were determined by two-way ANOVA. For all other
analysis, or when differences reached statistical significance by
two-way ANOVA, separate one-way ANOVA were performed
and, where appropriate, the LSD post-hoc test used to locate any
significant differences between time points. Significance was
accepted at the 5% level.
Results
Heart rate and mean arterial pressure
The LPS infusion resulted in early (1 h) and pronounced
tachycardia which persisted for the length of the LPS infusion
(Fig. 1), in addition to a biphasic fall in mean arterial pressure. The
speed of onset and degree of tachycardia and hypotension were
consistent with previous data obtained under similar conditions [24].
Figure 1. Heart rate and mean arterial pressure during
continuous LPS infusion. Values are mean6SEM; n=6 animals.
* significantly different from baseline (P,0.05).
doi:10.1371/journal.pone.0006945.g001
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A significant reduction (23%; P,0.05) in the ASP:DNA ratio
relative to controls was observed in the EDL after 24 h of LPS
infusion (Fig. 2A). This appeared the result of a decline in levels of
ASP in muscle extracts as opposed to a change in DNA content
(Fig. 2B), indicative of a decline in muscle protein content. In
contrast to skeletal muscle, there were no significant changes in
ASP levels, DNA content (Fig. 2B), or the ASP:DNA ratio (Fig. 2A)
of the myocardium at any time point compared to controls.
Ubiquitin-proteasome system, TNFa and IL-6
In the EDL there were markedly increased levels of MAFbx/
atrogin-1 and MuRF1 mRNA within 6 h after the onset of LPS
infusion (Fig. 3A & 3B respectively). Furthermore, interesting
differences in the time course of change in the levels of these two
ligases were observed. Thus, elevated levels of MAFbx/atrogin-1
mRNA at 6 h plateaued, whereas in contrast, MuRF1 mRNA
levels were substantially elevated from the 6 h to the 24 h time-
point. In addition, LPS administration resulted in the increased
levels of the a1 proteasome subunit mRNA in the EDL at all
examined time-points relative to control animals, but the change
was particularly pronounced 24 h after the start of the LPS-
infusion (Fig. 3C). Since the mRNA expression of individual
subunits of the 20S proteasome can vary in response to a catabolic
stimulus [30], the protein levels of subunits a1–3 and 5–7 were
also determined. In agreement with findings for the a1 subunit,
maximal protein levels for subunits a1–3 and 5–7 were observed in
the EDL following 24 h LPS administration (Fig. 3F). While only
animals subjected to 24 h LPS treatment underwent implantation
of arterial catheters into the distal abdominal aorta, the
reproducibility of the catabolic response to LPS in skeletal muscle
to previous findings where arterial catheters were not used [3],
suggest that the results observed were not due to prior surgical
intervention.
In stark contrast to the EDL, the myocardium did not display
altered mRNA levels for either MAFbx/atrogin-1 or MuRF1
following LPS administration at any of the three time-points
examined (Fig. 3A & 3B). Interestingly, however, increased mRNA
levels of the a1 proteasome subunit were detected in the
myocardium 6 h and 24 h from the start of the LPS infusion
(Fig. 3C), but the protein levels for multiple subunits of the 20S
proteasome were unaltered (Fig. 3F).
The mRNA levels of the two cytokines, TNFa and IL-6, were
examined to determine if they were in part responsible for any
tissue specific changes in translation initiation or muscle protein
breakdown pathways that were observed following LPS adminis-
tration. Transient and significant elevations of TNFa mRNA were
detected by 2 h of LPS administration in both EDL and
myocardium, peaking at 11-fold and 13-fold vs controls,
respectively (Figure 3D). Similarly, elevated levels of IL-6 mRNA
were detected by 2 h of LPS infusion in both tissues, although of a
much larger magnitude, peaking at 176-fold elevation of IL-6
mRNA in the EDL and .1000-fold in the myocardium vs
controls, following 2 h and 6 h LPS administration respectively
(Fig. 3E).
Translation initiation signalling
In the EDL, the total protein level of AKT was unaffected by a
24 h LPS infusion (Fig. 4A), although a trend (P=0.092) towards
reduced phosphorylation of AKT residue Ser
473 was detected
(Fig. 4B). 24 h LPS infusion had no effect on the protein level or
phosphorylation state of residues Thr
421 and Ser
424 of p70 S6K
(Fig. 4C & 4D), nor on the phosphorylation state of Thr
37 and
Thr
46 of 4E-BP1 (Fig. 4E), where both p70 S6K and 4E-BP1 are
located downstream of AKT.
In contrast to the EDL, a significant increase in AKT protein
was detected after 24 h LPS administration in the myocardium
(Fig. 4A). However, LPS-induced endotoxaemia did not appear to
have any significant effect on the phosphorylation state of residue
Ser
473 of AKT in the myocardium (Fig. 4B) nor on p70 S6K
protein levels (Fig. 4C). However, 24 h LPS-infusion did result in a
rise in the phosphorylation state of residues Thr
421 and Ser
424 of
p70 S6K (Fig. 4D) and Thr
37 and Thr
46 of 4E-BP1 (Fig. 4E),
indicative of a drive towards increased translation initiation in the
myocardium.
Discussion
Endotoxaemia in the rat results in a reduction in fast-twitch
skeletal muscle protein content by reducing protein synthesis [2]
and increasing protein breakdown [1], but it is currently unclear if
a decline in myocardial protein content also occurs under these
conditions, and whether any change observed is regulated by the
same signalling and genomic pathways as skeletal muscle. Here we
have shown myocardial protein content to be maintained at
normal levels following an administration of LPS sufficient to
Figure 2. Protein to DNA ratio in muscle and myocardium
following LPS infusion. A) ASP to DNA ratio following 2 h, 6 h and
24 h LPS infusion expressed as a percentage of treatment group
relative to control groups. Values represent mean6SEM. n=5–8 per
group. B) Quantity of alkaline soluble proteins and DNA in a 20 ml
aliquot of muscle extract. Solid lines indicate alkaline soluble proteins;
dashed lines, DNA; (%) mean of values from EDL of saline treated
animals; (D) EDL/LPS; (&) myocardium/saline and (m) myocardium/LPS.
By two-way ANOVA, significant differences were observed for main
effects of treatment (P=0.02) and time (P=0.03) and treatment-time
interaction (P=0.02). * indicates significantly different from control
(P,0.05).
doi:10.1371/journal.pone.0006945.g002
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to show this disparity between the two tissues in their response to
experimental endotoxaemia, is underpinned by differential
responses in the processes governing muscle protein synthesis
and muscle protein breakdown. The results of the present study
clearly demonstrate that the events associated with UP-mediated
muscle protein breakdown, as have been shown to occur in fast-
twitch muscle following LPS administration [3], appear largely
unaltered in the myocardium of LPS treated rats. Furthermore,
the results highlight several interesting changes that occur in the
mechanisms that regulate protein translation initiation in the
myocardium, changes that would generally be suggestive of an
enhancement of translation initiation. These observations, accom-
panied by the maintenance of myocardial, but not EDL protein
content, suggest that the myocardium during early endotoxaemia
does not experience the same catabolic fate as skeletal muscle.
While the ASP to DNA ratio was maintained in the
myocardium of LPS treated animals, previous published reports
detailing myocardial protein content during endotoxaemia, have
reported variable findings [15,17,31]. It is interesting to note that
where a decline in myocardial protein content has been reported,
it was following the induction of endotoxaemia via the use of the
cecal ligation and puncture technique in combination with the use
of non-sham-operated controls [15]. O’Leary and colleagues
demonstrated that performing a laporatomy, as required by the
CLP technique, results in significant reductions in myocardial
fractional protein synthesis rates and protein content, lasting for a
minimum of 72 h post completion of the surgical procedure [17].
Thus, the variations observed between studies could be the result
of methodological differences. Given the above findings, we would
propose that the use of the LPS model is more appropriate to the
clinical situation than CLP when considering the impact of
endotoxaemia on mechanisms regulating protein turnover in
rodent myocardium. However, given the sparse number of studies
that have examined this issue to date, it is not possible to preclude
temporal effects of endotoxaemia, induced by any one of the
various means, on myocardial protein content.
Consistent with our previously reported findings [3], we
observed 24 h LPS administration to result in reduced fast-twitch
skeletal muscle protein content, elevated mRNA levels of MAFbx/
atrogin-1 and MuRF1, and an increase in protein levels for
multiple subunits of the 20S proteasome; observations that are in
accordance with the reported rise in UP-mediated protein
degradation during endotoxaemia in fast-twitch muscle [32].
Interestingly, while a trend towards a fall in phosphorylation of
AKT residue Ser
473 was observed, it failed to reach statistical
significance (P=0.097), and moreover, elements examined
downstream of AKT (phosphorylation levels of p70 S6K and
4E-BP1) were unchanged by the LPS treatment protocol described
here. This is in contrast to our previously published findings where
declines in AKT Ser
473 phosphorylation and total protein levels of
AKT were reported in EDL following 24 h LPS treatment [3].
Furthermore, while levels of p70 S6K and 4E-BP1 were not
examined as part of the previous study, phosphorylation of other
downstream targets of AKT kinase activity, namely Foxo1 and
Foxo3, were shown to be similarly reduced. Likewise, Lang and
colleagues [16] have shown the bolus i.v. administration of LPS
(1 mg kg
21) to be sufficient to reduce muscle 4E-BP1 phosphor-
ylation after 24 h. Reasons for discrepancies between the results
described here with those of previously reported findings, are
Figure 3. mRNA levels for proteins associated with proteolysis in muscle and myocardium following LPS infusion. Bars denote fold
change in mRNA levels of A) MAFbx/atrogin-1, B) MuRF1, C) 20S proteasome subunit a1, D) TNFa and E) IL-6, compared to corresponding control
values in response to either a 2 h, 6 h or 24 h i.v. LPS infusion. A value.1 indicates greater than control mRNA levels and ,1 is lower then control
mRNA levels. Protein levels of 20S proteasome subunits a1–3 and 5–7 were measured to confirm mRNA results for subunit alpha-1 (panel F). Values
represent mean6SEM. n=6–8 per group. By two-way ANOVA, significant differences were observed in the EDL for the main effects of treatment in all
measures (P#0.02), and for time and treatment-time interaction in all measures bar TNFa and IL-6 mRNA levels (P#0.02). In the myocardium,
significant differences for the main effect of treatment were observed in all measures bar MAFbx/atrogin-1 mRNA levels and proteasome subunit
protein levels (P#0.03). Significant differences in main effects of time and treatment-time interaction were only observed for 20S proteasome subunit
a1 and IL-6 mRNA levels in the myocardium (P#0.002). * indicates different from corresponding control (P,0.05); { different from 2 h LPS-treated
muscle (P,0.05); { different from 6 h LPS-treated muscle (P,0.05).
doi:10.1371/journal.pone.0006945.g003
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Ser
473 phosphorylation would appear to have had no significant
impact on the two downstream translation initiation intermediates
p70 S6K and 4E-BP1. The findings as reported, would suggest
that derangements in UP-mediated muscle protein degradation
were predominantly responsible for the observed reductions in
EDL protein content, although direct measures of muscle protein
synthesis and muscle protein breakdown would have been useful in
providing further support of this view.
In stark contrast to the EDL, the protein content of the
myocardium was unaffected by 24 h LPS administration, although
an increase in phosphorylation of downstream elements of
translation initiation consistent with an enhancement of muscle
protein synthesis, in addition to the maintenance of MAFbx/
atrogin-1 and MuRF1 mRNA at normal levels, were observed.
One possible explanation for the divergent response seen between
skeletal muscle and myocardium during LPS-induced endotoxae-
mia is the increased rate of myocardial contraction that occurs, as
evidenced by the early, pronounced and sustained tachycardia
seen following the start of LPS administration. Two observations
described here are in support of this notion. Firstly, elevated
phosphorylation levels of residues Thr
421 and Ser
424 for p70 S6K
were observed in the myocardium of LPS-treated rats. p70 S6K
indirectly promotes the translation of target oligopyrimidine
(TOP) mRNAs which are almost exclusively confined to
transcripts that encode for ribosomal proteins and translation
factors. Contraction, at least in skeletal muscle, promotes the
increased phosphorylation of p70 S6K [33] and is known to be
involved in cardiac hypertrophy [34]. Secondly, we observed no
change in MAFbx/atrogin-1 and MuRF1 mRNA levels in
myocardial tissue following LPS administration. Jones et al. [29]
had previously shown contraction to be sufficient to reverse
Figure 4. Phosphorylation and protein levels of translation initiation intermediates in muscle and myocardium following LPS
infusion. Bars denote fold change in A) total AKT protein, B) phosphorylation levels of AKT residue Ser
473, C) total p70 S6K protein, D)
phosphorylation levels of p70 S6K residues Thr
421 and Ser
424 and E) phosphorylation levels of 4E-BP1 residues Ser
65 and Thr
70, in response to 24 h LPS
administration relative to control animals. n=8 per group. Values represent mean6SEM. * Indicates different from corresponding control (P,0.05).
doi:10.1371/journal.pone.0006945.g004
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vastus lateralis of healthy human subjects. Similar observations have
also been made in the gastrocnemius and soleus muscles of rats
subjected to spinal cord isolation, where brief bouts of high-load
isometric contractions were able to prevent the increased
expression of MAFbx/atrogin-1 and MuRF1 mRNA [35]. It is
possible therefore that myocardial contraction could be responsi-
ble for the maintenance of MAFbx/atrogin-1 and MuRF1 mRNA
at basal levels. In further support of this notion, elevated levels of
MAFbx/atrogin-1 and MuRF1 mRNA have been observed in the
myocardium following chronic heart failure induced via the
ligation of the left coronary artery, a condition where reduced
contractile activity of the myocardium is observed [36] and, more
importantly, regular exercise training has been shown to be
sufficient to significantly reduce myocardial MAFbx/atrogin-1 and
MuRF1 mRNA levels following experimental myocardial infarc-
tion in rats [37].
The mechanisms responsible for initiating the tissue specific
changes in protein catabolism during sepsis are poorly understood.
It has been widely suggested that the catabolic cytokines, TNFa
and IL-6, could, in part, be responsible for triggering the catabolic
events in skeletal muscle. Indeed, it has been demonstrated that
both can facilitate protein catabolism in skeletal muscle and
myocardium [20,38,39]. However, despite elevated local levels of
both TNFa and IL-6 in the skeletal muscle of septic animals, their
necessity for muscle atrophy to occur remains equivocal
[12,40,41]. It is interesting to note that significantly elevated levels
of TNFa and IL-6 mRNA were observed here in both the
myocardium and skeletal muscle, occurring as early as 2 h after
the start of LPS administration, a finding similar to that of others
[14,40,42]. Thus, elevation of TNFa and IL-6 mRNA levels
precedes increases in both MAFbx/atrogin-1 and MuRF1.
However, mechanisms by which the myocardium is protected
from perceived localised increases in TNFa and IL-6 remains
unclear. Furthermore, reasons for the significant transient
elevation of IL-6 mRNA are not possible to discern; however,
the dual association of IL-6 with both contractile dysfunction [43]
and cardioprotection [44] is intriguing and worthy of further
investigation.
In summary, the myocardium does not experience the same
reductions in protein content that are characteristically observed
in skeletal muscle following continuous LPS administration. It is
feasible that this is in part a consequence of the failure of the
myocardium to elicit events typically associated with UP-mediated
protein degradation, most notably MAFbx/atrogin-1 and MuRF1
mRNA elevation. It is also possible that events typical of enhanced
protein translation initiation occur in the myocardium during early
endotoxaemia, but this remains speculative with the lack of a
robust reduction of AKT phosphorylation in fast-twitch muscle.
The exact ‘trigger’ responsible for the tissue-specific response
remains unknown. Whether myocardial contraction is responsible
for mediating some of the observed differences during endotox-
aemia is unclear, but is consistent with the rapid and sustained
elevation in heart rate observed. Collectively, these findings
represent a significant addition to our understanding of the
response of skeletal and cardiac muscle to endotoxaemia and
highlight possible explanations for the disparity in observations
between these two tissues.
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